Trustee purchases a total of 242,000 shares under the stock incentive plan for SAINT BELLA GP(02508).
The Saint Bella Group (02508) announced that from May 7, 2026 to May 18, 2026, the trustee has purchased a total of 242,000 shares in the market according to the Saint Bella 2025 share award plan, with an average transaction price of approximately HK$3.87 per share, and a total transaction amount of approximately HK$935,000. As of the date of this announcement, the trustee has purchased a total of 5.401 million shares in the market, with a total transaction amount of approximately HK$22.719 million.
SAINT BELLA GP(02508) announced that from May 7, 2026 to May 18, 2026, the trustee purchased a total of 242,000 shares on the market under the Saint Bella 2025 Stock Incentive Plan, with an average trading price of approximately HK$3.87 per share, with a total transaction amount of approximately HK$935,000. As of the date of this announcement, the trustee has purchased a total of 5,401,000 shares on the market, with a total transaction amount of approximately HK$22,719,000.
Related Articles
US Stock Market Move | The new L9 Livis model is priced too high, causing Li Auto, Inc. Sponsored ADR Class A (LI.US) to plummet nearly 10% at the opening.
AI risks driving companies to increase investment in network protection! CrowdStrike (CRWD.US) and Zscaler (ZS.US) receive target price upgrades on Wall Street.
US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.
US Stock Market Move | The new L9 Livis model is priced too high, causing Li Auto, Inc. Sponsored ADR Class A (LI.US) to plummet nearly 10% at the opening.
AI risks driving companies to increase investment in network protection! CrowdStrike (CRWD.US) and Zscaler (ZS.US) receive target price upgrades on Wall Street.
US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.
